Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: Implications for anticoagulant monitoring

British Journal of Haematology

Volumn 168, Issue 5, 2015, Pages 719-727

  Chowdary, Pratima ^a   Adamidou, Despoina ^a   Riddell, Anne ^a   Aghighi, Saman ^a   Griffioen, Anja ^a   Priest, Paul ^a   Moghadam, Lida ^a   Kelaher, Nicholas ^a   Huq, Farah Y ^a   Kadir, Rezan A ^a   Tuddenham, Edward G ^a   Gatt, Alex ^a,b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b MATER DEI HOSPITAL   (Malta)

Author keywords

Anti Xa assay; Heart valves; Heparins; Pregnancy; Thrombin generation assay

Indexed keywords

BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MONITORING; DRUG RESPONSE; FEMALE; HUMAN; HYPERCOAGULABILITY; PATIENT SAFETY; PATIENT SELECTION; PHARMACOGENETICS; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL PERIOD; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK REDUCTION; THROMBIN TIME; THROMBOPHILIA; BLOOD; CLINICAL TRIAL; PHYSIOLOGIC MONITORING; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROCEDURES;

ADULT; ANTICOAGULANTS; FACTOR XA INHIBITORS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MONITORING, PHYSIOLOGIC; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RETROSPECTIVE STUDIES; THROMBIN TIME; THROMBOPHILIA;

EID: 84922823916     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13193     Document Type: Article

References (27)

1. Al Dieri, R., Alban, S., Beguin, S. & Hemker, H.C. (2004) Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. Journal of Thrombosis and Haemostasis, 2, 1395-1401.
2. Al Dieri, R., Alban, S., Beguin, S. & Hemker, H.C. (2006) Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight. Journal of Thrombosis and Haemostasis, 4, 83-89.
3. Baglin, T., Barrowcliffe, T.W., Cohen, A. & Greaves, M. (2006) Guidelines on the use and monitoring of heparin. British Journal of Haematology, 133, 19-34.
4. Bates, S.M., Greer, I.A., Pabinger, I., Sofaer, S. & Hirsh, J. (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest, 133, 844S-886S.
5. Bremme, K.A. (2003) Haemostatic changes in pregnancy. Best Practice & Research. Clinical Haematology, 16, 153-168.
6. Cantwell, R., Clutton-Brock, T., Cooper, G., Dawson, A., Drife, J., Garrod, D., Harper, A., Hulbert, D., Lucas, S., McClure, J., Millward-Sadler, H., Neilson, J., Nelson-Piercy, C., Norman, J., O'Herlihy, C., Oates, M., Shakespeare, J., de Swiet, M., Williamson, C., Beale, V., Knight, M., Lennox, C., Miller, A., Parmar, D., Rogers, J. & Springett, A. (2011) Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. British Journal of Obstetrics and Gynaecology, 118(Suppl. 1), 1-203.
7. Chan, W.S., Anand, S. & Ginsberg, J.S. (2000) Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Archives of Internal Medicine, 160, 191-196.
8. Chantarangkul, V., Clerici, M., Bressi, C., Giesen, P.L. & Tripodi, A. (2003) Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica, 88, 547-554.
9. Chunilal, S.D., Young, E., Johnston, M.A., Robertson, C., Naguit, I., Stevens, P., Galashan, D., Oskamp, M.L., Brennan, B. & Ginsberg, J.S. (2002) The aPTT response of pregnant plasma to unfractionated heparin. Thrombosis and Haemostasis, 87, 92-97.
10. Clark, P., Brennand, J., Conkie, J.A., McCall, F., Greer, I.A. & Walker, I.D. (1998) Activated protein c sensitivity, protein c, protein s and coagulation in normal pregnancy. Thrombosis and Haemostasis, 79, 1166-1170.
11. Garcia, D.A., Baglin, T.P., Weitz, J.I. & Samama, M.M. (2012) Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest, 141, e24S-e43S.
12. Gatt, A., van Veen, J.J., Woolley, A.M., Kitchen, S., Cooper, P. & Makris, M. (2008a) Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. Thrombosis and Haemostasis, 100, 350-355.
13. Gatt, A., van Veen, J.J., Bowyer, A., Woolley, A.M., Cooper, P., Kitchen, S. & Makris, M. (2008b) Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic international normalized ratio is not due to inflammation. British Journal of Haematology, 142, 946-952.
14. Gerotziafas, G.T., Petropoulou, A.D., Verdy, E., Samama, M.M. & Elalamy, I. (2007) Effect of the anti-factor xa and anti-factor iIa activities of low-molecular-weight heparins upon the phases of thrombin generation. Journal of Thrombosis and Haemostasis, 5, 955-962.
15. Greaves, M. (2002) Limitations of the laboratory monitoring of heparin therapy. scientific and standardization committee communications: on behalf of the control of anticoagulation subcommittee of the scientific and standardization committee of the international society of thrombosis and haemostasis. Thrombosis and Haemostasis, 87, 163-164.
16. Hemker, H.C. & Beguin, S. (1999) Endogenous thrombin potential. In: Laboratory Techniques in Thrombosis - a Manual: ECAT Assay Procedures (2nd Revised Edition of the ECAT Assay Procedures) (eds by J. Jespersen, R.M. Bertina & F. Haverkate ), pp. 63-78. Kluwer Academic Publishers BV, Dordrecht, The Netherlands.
17. Hemker, H.C., Giesen, P., Al Dieri, R., Regnault, V., de Smedt, E., Wagenvoord, R., Lecompte, T. & Beguin, S. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis, 33, 4-15.
18. Hemker, H.C., Al Dieri, R., De Smedt, E. & Beguin, S. (2006) Thrombin generation, a function test of the haemostatic-thrombotic system. Thrombosis and Haemostasis, 96, 553-561.
19. Levine, M.N., Planes, A., Hirsh, J., Goodyear, M., Vochelle, N. & Gent, M. (1989) The relationship between anti-factor xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement. Thrombosis and Haemostasis, 62, 940-944.
20. McLintock, C., McCowan, L.M. & North, R.A. (2009) Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. British Journal of Obstetrics and Gynaecology, 116, 1585-1592.
21. Quinn, J., Von Klemperer, K., Brooks, R., Peebles, D., Walker, F. & Cohen, H. (2009) Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience. Haematologica, 94, 1608-1612.
22. Rosenkranz, A., Hiden, M., Leschnik, B., Weiss, E.C., Schlembach, D., Lang, U., Gallistl, S. & Muntean, W. (2008) Calibrated automated thrombin generation in normal uncomplicated pregnancy 1. Thrombosis and Haemostasis, 99, 331-337.
23. Rossetto, V., Spiezia, L., Dabrilli, P., Gavasso, S. & Simioni, P. (2012) Effect on thrombin generation of the 'in vitro' addition of low-dose lMWH to plasma of healthy pregnant and nonpregnant women. Clinical and Applied Thrombosis/Hemostasis, 18, 331-333.
24. Saeed, C.R., Frank, J.B., Pravin, M., Aziz, R.H., Serasheini, M. & Dominique, T.G. (2011) A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves. Clinical and Applied Thrombosis/Hemostasis, 17, 313-319.
25. Stirling, Y., Woolf, L., North, W.R., Seghatchian, M.J. & Meade, T.W. (1984) Haemostasis in normal pregnancy. Thrombosis and Haemostasis, 52, 176-182.
26. Szecsi, P.B., Jorgensen, M., Klajnbard, A., Andersen, M.R., Colov, N.P. & Stender, S. (2010) Haemostatic reference intervals in pregnancy. Thrombosis and Haemostasis, 103, 718-727.
27. van Veen, J.J., Gatt, A. & Makris, M. (2008) Thrombin generation testing in routine clinical practice: are we there yet? British Journal of Haematology, 142, 889-903.